Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The purpose of this study is to evaluate the efficacy and safety of baricitinib as monotherapy in participants with moderate to severe atopic dermatitis.
Epistemonikos ID: 0474cfb66cafeb0f94d242f778d977c7ded10dd4
First added on: Dec 25, 2023